Journals / Acıbadem Üniversitesi Sağlık Bilimleri Dergisi / 2016 / Sayı: 3

Correlation Between Pet/ct Primary Tumor Fdg Uptake Levels and Lymph Node Metastases In Patients With Cervical Cancer

Serviks Kanserli Hastalarda PET/BT Tetkikinde Primer Tümörün FDG Tutulum Derecesi ile Lenf Nodu Metastazı Arasındaki İlişki

Pages
129–133
Publication Date
2016-09-01
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Two groups were statistically different according to the SUVmax levels and lymph node metastases p

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objectives: The aim of this study was to determine the correlation between Positron Emission Tomography/Computed Tomography PET/CT primary tumor FDG uptake levels and lymph node metastases in cervical cancer patients.Materials and methods: One hundred and three 103 cervical cancer patients who had pretreatment staging PET/CT were included in the study.
📊
Key Findings & Data:Results: Median age was 56 years range 31-91 years .
💡
Conclusion & Impact:Two groups were statistically different according to the SUVmax levels and lymph node metastases p
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:cervical cancer · PET/CT · SUVmax

Abstract

Objectives: The aim of this study was to determine the correlation between Positron Emission Tomography/Computed Tomography PET/CT primary tumor FDG uptake levels and lymph node metastases in cervical cancer patients.Materials and methods: One hundred and three 103 cervical cancer patients who had pretreatment staging PET/CT were included in the study. Primary tumor maximum standard uptake value SUVmax levels, maximum tumor diameter measured on PET/CT, FDGavid pelvic and paraaortic lymph nodes and SUVmax values for FDG-avid lymph nodes were recorded for every patient. Correlation between SUVmax levels and lymph node metastases were evaluated. Statistical analysis was done using SPSS. Results: Median age was 56 years range 31-91 years . Mean SUVmax levels for primary tumor and for lymph nodes were 14,3±6,3 range; 3,9-34,2 and 8,6±3,9 range; 2,8-19,3 , respectively. SUVmax levels for the patients with FDG-avid lymph nodes and non FDG-avid patients were 15,9 range; 4,1-34,2 and11,9 range; 3,9-25,5 p 4 cm there were lymph node metastases. Two groups were statistically different according to the SUVmax levels and lymph node metastases p

Özet

Amaç: Bu çalışmada, serviks kanserli hastalarda Pozitron Emisyon Tomografisi/Bilgisayarlı Tomografi PET/BT tetkikinde primer tümörün FDG tutulum derecesi ile lenf nodu metastazı arasındaki ilişkinin saptanması amaçlandı.Gereç ve yöntem: Tedavi öncesi evreleme amacıyla PET/BT tetkiki yapılan 103 hasta çalışmaya dahil edildi. Primer tümörün maksimum standart uptake SUVmaks değeri, PET/BT tetkikinde ölçülen maksimum tümör çapı, pelvik ve paraaortik lenf nodlarında FDG tutulumu olup olmadığı ve FDG tutulumu olan lenf nodlarında SUVmaks değerleri her hasta için kaydedildi. SUVmaks değerlerinin lenf nodu metastazı ile ilişkisi araştırıldı. İstatistiksel analiz SPSS programı ile yapıldı. Bulgular: Ortanca yaş 56 idi 31-91 arası . SUVmaks ortalama değerleri primer tümör için 14,3±6,3 3,9-34,2 arası ve lenf nodları için 8,6±3,9 2,8-19,3 arası idi. Lenf nodu tutulumu olan ve olmayan hastalarda SUVmaks ortalama değerleri sırasıyla 15,9 4,1-34,2 arası ve 11,9 3,9-25,5 arası idi p 4 cm olan hastaların %66’sında lenf nodu tutulumu vardı. SUVmaks değerleri ve lenf nodu FDG tutulumu açısından iki grup arasındaki fark istatistiksel olarak anlamlıydı p

🔖

Cite This Article

UĞURLUER, G., ATALAR, B., İKİZLER, H. A. S., SÖZER, N., KİBAR, M., SERİN, M., ÖZYAR, E. (2016). Correlation Between Pet/ct Primary Tumor Fdg Uptake Levels and Lymph Node Metastases In Patients With Cervical Cancer. Acıbadem Üniversitesi Sağlık Bilimleri Dergisi, Sayı: 3, 129–133. https://ajindex.com/articles/163084

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (10)

  1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin, 2011; 61: 69-90.
  2. Kamangar F, Dores GM, Anderson WF. Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world. J Clin Oncol, 2006; 24: 2137-50. National Comprehensive Cancer Network. Cervical Cancer. (Version 1.2016). http://www.nccn.org/professionals/physician_gls/pdf/ cervical.pdf. Erişim tarihi 4 Mart 2016. Kjær SK, Frederiksen K, Munk C, Iftner T. Long-term absolute risk of cervical intraepithelial neoplasia grade 3 or worse following human papillomavirus infection: role of persistence. J Natl Cancer Inst. 2010; 102: 1478-88. International Collaboration of Epidemiological Studies of Cervical Cancer. Comparison of risk factors for invasive squamous cell carcinoma and adenocarcinoma of the cervix: collaborative reanalysis of individual data on 8,097 women with squamous cell carcinoma and 1,374 women with adenocarcinoma from 12 epidemiological studies. Int J Cancer, 2007; 120: 885-91.
  3. Kidd EA, Siegel BA, Dehdashti F, Grigsby PW. Pelvic lymph node F-18 fluorodeoxyglucose uptake as a prognostic biomarker in newly diagnosed patients with locally advanced cervical cancer. Cancer, 2010; 116: 1469-75.
  4. Tinga DJ, Timmer PR, Bouma J, Aalders JG. Prognostic significance of single versus multiple lymph node metastases in cervical carcinoma stage IB. Gynecol Oncol, 1990; 39: 175-80.
  5. Stehman FB, Bundy BN, DiSaia PJ, Keys HM, Larson JE, Fowler WC. Carcinoma of the cervix treated with radiation therapy. I. A multi- variate analysis of prognostic variables in the Gynecologic Oncology Group. Cancer, 1991; 67: 2776-85.
  6. Pecorelli S, Zigliani L, Odicino F. Revised FIGO staging for carcinoma of the cervix. Int J Gynaecol Obstet, 2009; 105: 107-8.
  7. Kidd EA, Siegel BA, Dehdashti F, Rader JS, Mutch DG, Powell MA, ve ark. Lymph node staging by positron emission tomography in cervical cancer: relationship to prognosis. J Clin Oncol, 2010; 28: 2108-13.
  8. Scheidler J, Hricak H, Yu KK, Subak L, Segal MR. Radiological evaluation of lymph node metastases in patients with cervical cancer. A meta-analysis. JAMA, 1997; 278: 1096-101.
  9. Juweid ME, Cheson BD. Positron-emission tomography and assessment of cancer therapy. N Engl J Med. 2006; 354: 496-507.
  10. Cox BL, Mackie TR, Eliceiri KW. The sweet spot: FDG and other 2-carbon glucose analogs for multi-modal metabolic imaging of tumor m